OTC Watch

All stocks / CBIH

Cannabis Bioscience International Holdings, Inc. CBIH

Cannabis Bioscience International Holdings (CBIH): a late 10-Q notice in October 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.

Late filingEstimated float Pink LimitedTexas, USA
Live quote on OTC Markets

Market listing

Full name
CANNABIS BIOSCIENCE INTL HLDGS
Market tier
OTC Pink Limited
Trading status
Active
Last trade
Nov 13
Website
www.cbih.net/
Source: Stockwatch, 2026-11-17

News headlines

CBIH Announces Expanded Research Strategy at the Intersection of Endocannabinoid Science and Biological Medicine
2026-10-19 07:03 · News Release
CBIH Unveils Cannabinoid-Based Intranasal Platform for Alzheimer's Research
2026-07-20 07:01 · News Release
Years of Preparation. One Regulatory Approval. Commercial Launch Begins: CBIH Receives Texas License for Consumable Hemp Products
2026-07-15 07:01 · News Release
CBIH Announces Recognition Initiative Funded Through CEO's Personal Share Holdings
2026-07-06 07:02 · News Release
Cannabis Bioscience International Holdings Opens New Revenue Pathway with First VitaCookies Licensing Agreement
2026-06-22 07:02 · News Release
CBIH Announces Patent-Related Scientific Framework for PTSD-Focused Cannabinoid and Psilocybin Research
2026-06-15 07:02 · News Release
CBIH Advances Strategic Pathway to Bring VitaCookies' Science-Driven Functional Wellness Platform to Texas Consumers
2026-06-08 07:02 · News Release
CBIH Completes Cannabinoid-Based Melanoma Patent Application Program Focused on Cannabinoid Science and Epigenetic Regulation
2026-06-01 07:02 · News Release
CBIH Evaluates a Potential Reg A Offering of Approximately $1,000,000 to Enable Commercial Launch, Statewide Educational Expansion, and Protection of Its Patent Portfolio
2026-01-21 07:02 · News Release
CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr. Mehmet Oz's Team and an "Evidence Sprint 2026" Focused on Grants, Research and Clinical Evidence
2026-01-12 07:01 · News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2025-05-31
The report says
Revenue
$303,022
Net loss
($548,820)
What it means

It spends more than it earns

Under strain

Customers paid it $303,022 in the year. It lost $548,820. For every $1 that came in, about $2.81 went out.

The report says
Cash and cash equivalents
$12,952
Net cash used in operating activities
($329,627)
What it means

The cash could run out soon

Under strain

It had $12,952 in the bank and used about $27,469 a month. At that pace the money lasts less than a month unless it borrows or sells more shares.

The report says
Total assets
$31,880
Total liabilities
$1,195,463
What it means

It owes more than it owns

Under strain

Everything the company owns adds up to $31,880. Its debts and unpaid bills add up to $1.2 million. That is about $37.50 owed for every $1 owned.

What this adds up to

3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.

Signals

Late filing2026-10-16

Filed NT 10-Q on 2026-10-16: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Late filing2026-08-31

Filed NT 10-K on 2026-08-31: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Estimated float2026-04-16

Estimated float about 11,626,749,347 shares as of 2026-04-16: 11,626,749,347 outstanding minus 0 held by 0 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Late filing2026-04-14

Filed NT 10-Q on 2026-04-14: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Late filing2026-01-14

Filed NT 10-Q on 2026-01-14: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Shares outstanding

Source: SEC filings
2025-05-31
11.63B
2025-08-31
11.63B
2025-09-22
11.63B
2025-10-22
11.63B
2025-11-30
11.63B
2026-02-18
11.63B
2026-02-28
11.63B
2026-04-16
11.63B

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-10-16 NT 10-Q10-Q EXTENSION FOR AUGUST 2026
2026-08-31 NT 10-KFORM 10-K EXTENSION
2026-07-01 253G2FORM 253G2
2026-05-21 253G2FORM 253G2
2026-05-11 144
2026-04-16 10-QFORM 10-Q FEB 2026
2026-04-15 253G2FORM 253G2
2026-04-14 NT 10-QEXTENSION
2026-04-13 QUALIF
2026-04-08 CORRESP
2026-04-01 UPLOAD
2026-03-27 1-A

Common questions about CBIH

Does CBIH file reports with the SEC?

Yes. Cannabis Bioscience International Holdings files with the SEC under company number 0001411057. The most recent filing we hold is a NT 10-Q dated 2026-10-16.

Source record

How many CBIH shares are outstanding?

11,626,749,347 shares as of 2026-04-16, as reported to the SEC.

Source record

Has CBIH filed reports late?

Yes. In the last 12 months it filed 4 late-filing notices, most recently a NT 10-Q on 2026-10-16. A notice means a report was not ready on time; check whether the report followed.

Source record

Is Cannabis Bioscience International Holdings making money?

Customers paid it $303,022 in the year. It lost $548,820. For every $1 that came in, about $2.81 went out. (Annual figures to 2025-05-31. Facts from the company's own report, not a recommendation.)

Source record